Cemig Q4 2025 slides: earnings miss overshadowed by record capex

Cemig missed EPS expectations with Q4 EPS of $0.0541 vs $0.0665 consensus (-18.65%), but shares rose ~2.6% premarket as investors focused on strategic positives. Full-year recurring EBITDA fell to R$7.3bn (-4%) and recurring net profit to R$4.1bn (-9.3%), while net debt rose to R$16.8bn and net debt/recurring EBITDA increased to 2.30x. Management executed a record R$6.6bn capex program, secured concession extensions and a Moody’s upgrade to AAA, and returned R$3.5bn to shareholders (14.9% yield), supporting longer-term outlook despite near-term hydrological and leverage pressures.

Analysis

Completed large, well-timed infrastructure spend together with a longer-dated regulatory asset recovery profile is changing Cemig’s risk/return trade-off from short-cycle merchant exposure to a longer-duration regulated cash flow story. That shift benefits capital goods and O&M suppliers with long lead times for distribution upgrades and boosts demand for longer-dated, inflation-linked debt issuance in local markets — a supply/demand dynamic that can compress credit spreads for issuers with similar regulatory visibility.

The principal near-term swing factor remains hydrology-driven spot price volatility; a single dry season or a stronger-than-expected El Niño could swing free cash flow materially within months and force either accelerated asset monetization or dividend cuts. Elevated leverage with a high share of floating-rate or indexed paper increases sensitivity to Brazil rate moves, so the company’s financing flexibility is a function of macro path as much as operational execution.

From a credit market angle, an issuer moving from merchant-to-regulated profile will attract long-duration, ESG-oriented capital but also invites scrutiny on contingent liabilities (legacy labor/healthcare settlements) that are scheduled over multi-year windows — those payments are a liquidity cadence investors can front-run or hedge. Operational KPIs improving below inflation imply margin upside if spot pressures normalize, creating a clear asymmetric payoff for patient holders who hedge short-term hydrology and rate risks.

Contrarian risk: market pricing appears to be compressing valuation volatility too quickly — near-term sympathy for high-yield carry may underprice seasonal stress scenarios. Conversely, the market may still underappreciate how a larger regulatory asset base can mechanically lift tariff-backed cash flows over several years, meaning the sell-side downside in a normalized hydrology outcome could be limited.

Key Decisions for Investors

• Long CIG.C equity (size 3–5% of EM utilities sleeve) on pullbacks within the next 1–3 months; horizon 6–12 months. Hedge hydrology risk by buying a 9–12 month protective put (strike ~20% out) to cap downside; target total return +25% (price appreciation + distributions) vs downside ~20% if severe dry season.
• Income-seeking trade: buy long-dated, inflation-linked Cemig debentures or hold senior IG Brazilian utility bonds (size 5% credit bucket) — horizon 1–4 years. Rationale: secular RAB growth and ESG demand should compress spreads; event risk is liquidity timing from legacy payments, so cap position size and ladder maturities to 2029–2035.
• Relative-value pair: long CIG.C / short a pure distributed-generation focused Brazilian peer (or DG-heavy ETF) — horizon 6–12 months. This isolates tariff/RAB capture vs structural DG headwinds; expect 1.5–2.5x beta to hydrology for the pair and use a 8–12% stop-loss on the short leg.
• Directional sector play: buy MCO and SPGI (timing 3–9 months) as convex beneficiaries from increased structured issuance and advisory flows in EM utilities and ESG-labeled debt. Position size modest (1–2% each); downside if issuance stalls is limited but monitor global banking stress and primary market volumes.